Search research articles
Contact Us
Filters
Showing results (101-110 of 111) with videos related to
Page
of 12
Sort By:
Advanced Functional Materials
|
April 2, 2026
Noninvasive Assessment of Protease Activity in Osteosarcoma via Click Chemistry-Mediated Enrichment of Extracellular Vesicles
You-Ren Ji, Junseok Lee, Hyoyong Kim, et al.
Cancer Cell
|
May 16, 2018
The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma
Milica Momcilovic, Sean T Bailey, Jason T Lee, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2023
The landscape of drug sensitivity and resistance in sarcoma
Ahmad Al Shihabi, Peyton J Tebon, Huyen Thi Lam Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 14, 2025
Erratum: Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors
Leo Mascarenhas, Steven G DuBois, Catherine M Albert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2025
Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors
Leo Mascarenhas, Steven G DuBois, Catherine M Albert, et al.
Signal Transduction and Targeted Therapy
|
September 29, 2025
Development of a leucine-rich repeat-containing protein 15-targeted radio-immunotheranostic approach to deplete pro-tumorigenic mechanisms and immunotherapy resistance
Claire M Storey, Mohamed Altai, Katharina Lückerath, et al.
The Lancet. Oncology
|
February 28, 2020
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
David S Hong, Steven G DuBois, Shivaani Kummar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 7, 2023
Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Smita Bhatia, Alberto S Pappo, Melissa Acquazzino, et al.
Nature Communications
|
July 2, 2025
Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny
Theodore S Nowicki, Nataly Naser Al Deen, Cole W Peters, et al.
The New England Journal of Medicine
|
February 22, 2018
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
Alexander Drilon, Theodore W Laetsch, Shivaani Kummar, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 111) with videos related to
Sort By:
Page
of 12
Advanced Functional Materials
|
April 2, 2026
Noninvasive Assessment of Protease Activity in Osteosarcoma via Click Chemistry-Mediated Enrichment of Extracellular Vesicles
You-Ren Ji, Junseok Lee, Hyoyong Kim, et al.
Cancer Cell
|
May 16, 2018
The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma
Milica Momcilovic, Sean T Bailey, Jason T Lee, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2023
The landscape of drug sensitivity and resistance in sarcoma
Ahmad Al Shihabi, Peyton J Tebon, Huyen Thi Lam Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 14, 2025
Erratum: Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors
Leo Mascarenhas, Steven G DuBois, Catherine M Albert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2025
Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors
Leo Mascarenhas, Steven G DuBois, Catherine M Albert, et al.
Signal Transduction and Targeted Therapy
|
September 29, 2025
Development of a leucine-rich repeat-containing protein 15-targeted radio-immunotheranostic approach to deplete pro-tumorigenic mechanisms and immunotherapy resistance
Claire M Storey, Mohamed Altai, Katharina Lückerath, et al.
The Lancet. Oncology
|
February 28, 2020
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
David S Hong, Steven G DuBois, Shivaani Kummar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 7, 2023
Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Smita Bhatia, Alberto S Pappo, Melissa Acquazzino, et al.
Nature Communications
|
July 2, 2025
Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny
Theodore S Nowicki, Nataly Naser Al Deen, Cole W Peters, et al.
The New England Journal of Medicine
|
February 22, 2018
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
Alexander Drilon, Theodore W Laetsch, Shivaani Kummar, et al.
Page
of 12